Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells

Abstract Targeted pharmacologic activation of antigen-specific (AgS) T cells may bypass limitations inherent in current T cell-based cancer therapies. We describe two immunotherapeutics platforms for selective delivery of costimulatory ligands and peptide-HLA (pHLA) to AgS T cells. We engineered and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ronald D. Seidel, Zohra Merazga, Dharma Raj Thapa, Jonathan Soriano, Emily Spaulding, Ahmet S. Vakkasoglu, Paige Ruthardt, Wynona Bautista, Steven N. Quayle, Peter A. Kiener, Simon Low, John F. Ross, Saso Cemerski, Anish Suri, Steven C. Almo, Rodolfo J. Chaparro
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/897c1421d763409b9b5cd4b0353c9706
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:897c1421d763409b9b5cd4b0353c9706
record_format dspace
spelling oai:doaj.org-article:897c1421d763409b9b5cd4b0353c97062021-12-02T18:51:15ZPeptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells10.1038/s41598-021-98716-z2045-2322https://doaj.org/article/897c1421d763409b9b5cd4b0353c97062021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-98716-zhttps://doaj.org/toc/2045-2322Abstract Targeted pharmacologic activation of antigen-specific (AgS) T cells may bypass limitations inherent in current T cell-based cancer therapies. We describe two immunotherapeutics platforms for selective delivery of costimulatory ligands and peptide-HLA (pHLA) to AgS T cells. We engineered and deployed on these platforms an affinity-attenuated variant of interleukin-2, which selectively expands oligoclonal and polyfunctional AgS T cells in vitro and synergizes with CD80 signals for superior proliferation versus peptide stimulation.Ronald D. SeidelZohra MerazgaDharma Raj ThapaJonathan SorianoEmily SpauldingAhmet S. VakkasogluPaige RuthardtWynona BautistaSteven N. QuaylePeter A. KienerSimon LowJohn F. RossSaso CemerskiAnish SuriSteven C. AlmoRodolfo J. ChaparroNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ronald D. Seidel
Zohra Merazga
Dharma Raj Thapa
Jonathan Soriano
Emily Spaulding
Ahmet S. Vakkasoglu
Paige Ruthardt
Wynona Bautista
Steven N. Quayle
Peter A. Kiener
Simon Low
John F. Ross
Saso Cemerski
Anish Suri
Steven C. Almo
Rodolfo J. Chaparro
Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells
description Abstract Targeted pharmacologic activation of antigen-specific (AgS) T cells may bypass limitations inherent in current T cell-based cancer therapies. We describe two immunotherapeutics platforms for selective delivery of costimulatory ligands and peptide-HLA (pHLA) to AgS T cells. We engineered and deployed on these platforms an affinity-attenuated variant of interleukin-2, which selectively expands oligoclonal and polyfunctional AgS T cells in vitro and synergizes with CD80 signals for superior proliferation versus peptide stimulation.
format article
author Ronald D. Seidel
Zohra Merazga
Dharma Raj Thapa
Jonathan Soriano
Emily Spaulding
Ahmet S. Vakkasoglu
Paige Ruthardt
Wynona Bautista
Steven N. Quayle
Peter A. Kiener
Simon Low
John F. Ross
Saso Cemerski
Anish Suri
Steven C. Almo
Rodolfo J. Chaparro
author_facet Ronald D. Seidel
Zohra Merazga
Dharma Raj Thapa
Jonathan Soriano
Emily Spaulding
Ahmet S. Vakkasoglu
Paige Ruthardt
Wynona Bautista
Steven N. Quayle
Peter A. Kiener
Simon Low
John F. Ross
Saso Cemerski
Anish Suri
Steven C. Almo
Rodolfo J. Chaparro
author_sort Ronald D. Seidel
title Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells
title_short Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells
title_full Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells
title_fullStr Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells
title_full_unstemmed Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells
title_sort peptide-hla-based immunotherapeutics platforms for direct modulation of antigen-specific t cells
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/897c1421d763409b9b5cd4b0353c9706
work_keys_str_mv AT ronalddseidel peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
AT zohramerazga peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
AT dharmarajthapa peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
AT jonathansoriano peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
AT emilyspaulding peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
AT ahmetsvakkasoglu peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
AT paigeruthardt peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
AT wynonabautista peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
AT stevennquayle peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
AT peterakiener peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
AT simonlow peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
AT johnfross peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
AT sasocemerski peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
AT anishsuri peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
AT stevencalmo peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
AT rodolfojchaparro peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells
_version_ 1718377458736037888